http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120021316-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fd15d8ebb22202b5cfe2b109cd922c5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5058 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0619 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-079 |
| filingDate | 2012-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0902dd74482bf3fa3927280503c22a06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_336ca818fb8eae197b6760be80375815 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e0239b8a412ff1b99c897b9982edf73 |
| publicationDate | 2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120021316-A |
| titleOfInvention | DJ-1 loss cell line for the acquisition of pathological markers applicable to the diagnosis of Parkinson's disease |
| abstract | The present invention relates to a novel DJ-1 (DJ-1) loss mutant cell line that can detect Parkinson's pathogene markers, and the treatment for the prevention, treatment and progression of disease from Parkinson's disease from pathogene markers detected using the same. The present invention relates to a method for screening Parkinson's disease inhibitors using diagnostic kits and Parkinson's pathological markers that can be used for drug search and clinical diagnosis. Gene markers according to the present invention can be used in clinical diagnosis as a target gene marker that causes a decrease in the function of black matter when the expression is increased or decreased by DJ-1 (DJ-1) loss mutant cell line, Parkinson's disease can be used for clinical diagnosis, and it can be used as a cell-based measurement tool in the search for customized neuroprotective therapy for degenerative chronic brain disease for the treatment, prevention and alleviation of symptoms. . |
| priorityDate | 2012-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 156.